Burguera B, Agusti A, Arner P, Baltasar A, Barbe F, Barcelo A, Breton I, Cabanes T, Casanueva FF, Couce ME, Dieguez C, Fiol M, Fernandez Real JM, Formiguera X, Fruhbeck G, Garcia Romero M, Garcia Sanz M, Ghigo E, Gomis R, Higa K, Ibarra O, Lacy A, Larrad A, Masmiquel L, Moizé V, Moreno B, Moreiro J, Ricart W, Riesco M, Salinas R, Salvador J, Pi-Sunyer FX, Scopinaro N, Sjostrom L, Pagan A, Pereg V, Sánchez Pernaute A, Torres A, Urgeles JR, Vidal-Puig A, Vidal J, Vila M
Critical assessment of the current guidelines for the management and treatment of morbidly obese patients.
Miranda M, Chacón MR, Gómez J, Megía A, Ceperuelo-Mallafré V, Veloso S, Saumoy M, Gallart L, Richart C, Fernández-Real JM, Vendrell J
Human subcutaneous adipose tissue LPIN1 expression in obesity, type 2 diabetes mellitus, and human immunodeficiency virus-associated lipodystrophy syndrome
Ong KK, de Zegher F, López-Bermejo A, Dunger DB, Ibáñez L
Flutamide-metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype
Vazquez-Martin A, Colomer R, Brunet J, Menendez JA
Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31, 769-776